LabMed Discovery is a high-quality, peer-reviewed, and open-access English journal of laboratory medicine. Sponsored by Ruijin Hospital and SJTU.
- Tweets313
- Following112
- Followers20
- Likes180
ALT Plus an inspiring Editorial by Editor-in-Chief Prof. Khosrow Adeli on advancing lab medicine from discovery to diagnosis. 🔓 Diamond #OpenAccess | Read now: https://www.sciencedirect.com/journal/labmed-discovery
ALT 🦠 Which Mycobacterium is causing the infection—and can we identify it within hours? 🔬 A new #LabMedDiscovery commentary highlights CANDI, a CRISPR–nanodroplet platform enabling rapid, multiplexed, species-level identification of clinically relevant mycobacteria. 🧬 Broad-range amplification 🎯 CRISPR-based species recognition 💧 Nanodroplet barcoding ⚡ Results within hours 🔎 Detection of mixed infections Prof. Dakang Xu’s team discusses how this innovative strategy could reshape rapid mycobacterial diagnostics—and its potential for broader multiplex molecular testing. 📖 Yang Y, Xu J, Xu D. LabMed Discovery. 2026;3(3):100149. 🔗 https://doi.org/10.1016/j.lmd.2026.100149 #CRISPR #Mycobacteria #MolecularDiagnostics #LaboratoryMedicine #Microbiology #Diagnostics
ALT 🚀 Publish your research with LabMed Discovery! Looking for a global platform to share your breakthroughs in Laboratory Medicine?https://sciencedirect.com/journal/labmed-discovery
ALT The biggest challenge for AI in pathology is no longer accuracy. It is adoption. Why do powerful AI models remain research prototypes while clinical implementation remains limited? This review reveals the hidden barriers: 🧬 Data instability 🏥 Workflow mismatch 🔐 Trust and governance gaps A new roadmap is proposed to bridge the gap between AI innovation and real-world clinical value.
